검색어: pantoprazol (크로아티아어 - 영어)

pantoprazol
pantoprazole

djelatna tvar je pantoprazol.
the active substance is pantoprazole.

dekslanzoprazol esomeprazol lanzoprazol pantoprazol rabeprazol
dexlansoprazole esomeprazole lansoprazole pantoprazole rabeprazole

bolesnici ne smiju uzimati pantoprazol profilaktički.
patients should not take pantoprazole as a preventive medicinal product.

controloc control 20 mg želučanootporne tablete pantoprazol
controloc control 20 mg gastro-resistant tablets pantoprazole

pantoprazol se metabolizira gotovo isključivo u jetri.
pantoprazole is almost exclusively metabolized in the liver.

omeprazol, esomeprazol, dekslanzoprazol, lanzoprazol, pantoprazol, rabeprazol
omeprazole, esomeprazole, dexlansoprazole, lansoprazole, pantoprazole, rabeprazole

pantoprazol se nakon peroralne primjene potpuno i brzo apsorbira.
pantoprazole is completely and rapidly absorbed after oral administration.

ispitivanja na životinjama su pokazala da se pantoprazol izlučuje u mlijeku.
animal studies have shown excretion of pantoprazole in breast milk.

antacide i pantoprazol (koriste se za liječenje želučanih tegoba),
antacids and pantoprazole (used to treat upset stomach)

kako se pantoprazol u velikoj mjeri veže na proteine, ne dijalizira se lako.
as pantoprazole is extensively protein bound, it is not readily dialysable.

inhibitori protonske pumpe, kao što su omeprazol, esomeprazol, lanzoprazol, pantoprazol, rabeprazol
proton pump inhibitors, such as omeprazole, esomeprazole, lansoprazole, pantoprazole, rabeprazole the systemic glucocorticoid dexamethasone, except as a single dose treatment

zato se pantoprazol ne smije primjenjivati istodobno s atazanavirom (vidjeti dio 4.3).
therefore, pantoprazole must not be co-administered with atazanavir (see section 4.3).

inhibitori protonske pumpe, kao što su omeprazol, esomeprazol, lansoprazol, pantoprazol, rabeprazol;
proton pump inhibitors, such as omeprazole, esomeprazole, lansoprazole, pantoprazole, rabeprazole; the systemic glucocorticoid dexamethasone, except as a single dose treatment;

controloc control sadrži djelatnu tvar pantoprazol, koja blokira „pumpu“ koja proizvodi želučanu kiselinu.
controloc control contains the active substance pantoprazole, which blocks the ‘pump’ that produces stomach acid.

pantoprazol: istodobna primjena pantoprazola (80 mg, jedanput dnevno) ne mijenja farmakokinetiku sinakalceta.
pantoprazole: co-administration of pantoprazole (80 mg, once daily) did not alter the pharmacokinetics of cinacalcet.

istovremena primjena inhibitora protonske pumpe kao što su omeprazol ili pantoprazol može dovesti do interakcija: istovremena primjena metotreksata i omeprazola dovela je do odgođene eliminacije metotreksata putem bubrega.
co-administration of proton-pump inhibitors such as omeprazole or pantoprazole can lead to interactions: concomitant administration of methotrexate and omeprazole has led to a delay in the renal elimination of methotrexate.

primijećeno je smanjenje izloženosti mpa-u u slučajevima kada su antacidi, poput magnezijevog i aluminijevog hidroksida te ipp, uključujući lanzoprazol i pantoprazol bili primjenjivani zajedno s lijekom cellcept.
decreased mpa exposure has been observed when antacids, such as magnesium and aluminium hydroxides, and ppis, including lansoprazole and pantoprazole, were administered with cellcept.

pantoprazol: kada je pradaxa primjenjivana istodobno s pantoprazolom, opaženo je smanjenje područja ispod krivulje koncentracije u plazmi-vrijeme dabigatrana za oko 30 %.
pantoprazole: when pradaxa was co-administered with pantoprazole, a decrease in the dabigatran area under the plasma concentration-time curve of approximately 30 % was observed.

pantoprazol (40 mg jednom na dan), lijek koji povećava želučani ph, ali pritom ne utječe na enzime citokrom p450, nije značajno djelovao na farmakokinetiku dronedarona.
pantoprazole (40 mg once daily), a medicinal product which increases gastric ph without any effect on cytochrome p450, did not interact significantly on dronedarone pharmacokinetics.